Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical PDT With Levulan Kerastick for Benign Dermal Neurofibromas
NCT02728388Phase 2Terminated
- Start
- Sep 2016
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aminolevulinic acid 10% gel in neurofibromatosis type 1 (NF1). Started Sep 2016; status: terminated.
02
Drugs
aminolevulinic acid 10% gel
03
Conditions
neurofibromatosis type 1 (NF1)
Beyond the preview
Go deeper on NCT02728388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02728388.